Other substances

Myricitrin

A glycosyloxyflavone.

Phase of research

Potential treatment - theoretical effect

How it helps

Antiviral

Drug status

Natural product

1
 Supporting references
0
 Contradictory references
6
 AI-suggested references
0
 Clinical trials

General information

A natural (glycosyloxyflavone) compound isolated from Myrica cerifera, it exhibits anti-allergic activity (ChEBI).

Myricitrin on PubChem
Myricitrin on Wikipedia

 

Structure image - Myricitrin

C[C@H]1[C@@H]([C@H]([C@H]([C@@H](O1)OC2=C(OC3=CC(=CC(=C3C2=O)O)O)C4=CC(=C(C(=C4)O)O)O)O)O)O

Supporting references

Link Tested on Impact factor Notes Publication date
Identification of potential anti-TMPRSS2 natural products through homology modelling, virtual screening and molecular dynamics simulation studies
in silico 3.31

In silico TMPRSS2 inhibitors screening.

 Aug/03/2020

AI-suggested references

Link Publication date
Structural Bioinformatics Used to Predict the Protein Targets of Remdesivir and Flavones in SARS-CoV-2 Infection.
Oct/08/2021
Development of Effective Therapeutic Molecule from Natural Sources against Coronavirus Protease
May/27/2020
Identification of phytochemical inhibitors of SARS-CoV-2 protease 3CLpro from selected medicinal plants as per molecular docking, bond energies and amino acid binding energies
Mar/24/2022
Discovery of potential multi-target-directed ligands by targeting host-specific SARS-CoV-2 structurally conserved main protease
Mar/08/2021
Inhibition of SARS-CoV-2 main protease by phenolic compounds from Manilkara hexandra (Roxb.) Dubard assisted by metabolite profiling and in silico virtual screening
Apr/17/2022
Food phytochemicals, epigallocatechin gallate and myricetin, covalently bind to the active site of the coronavirus main protease in vitro.
Oct/08/2021
Export (.csv)